These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5062540)

  • 1. Two progressive inhibitors of factor Xa in human blood.
    Marciniak E; Tsukamura S
    Br J Haematol; 1972 Mar; 22(3):341-51. PubMed ID: 5062540
    [No Abstract]   [Full Text] [Related]  

  • 2. Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.
    Yin ET; Wessler S; Stoll PJ
    J Biol Chem; 1971 Jun; 246(11):3712-9. PubMed ID: 4102937
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombin 3, antifactor Xa and heparin.
    Biggs R; Denson KW; Akman N; Borrett R; Hadden M
    Br J Haematol; 1970 Sep; 19(3):283-305. PubMed ID: 5529547
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for anticoagulation with synthetic protease inhibitors. Xa inhibitors versus thrombin inhibitors.
    Tidwell RR; Webster WP; Shaver SR; Geratz JD
    Thromb Res; 1980 Aug; 19(3):339-49. PubMed ID: 7434318
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor.
    Yin ET
    Thromb Diath Haemorrh; 1975 Feb; 33(1):43-50. PubMed ID: 47195
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths.
    Wagenvoord R; Al Dieri R; van Dedem G; Béguin S; Hemker HC
    Thromb Res; 2008; 122(2):237-45. PubMed ID: 18045667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex.
    Marciniak E
    Br J Haematol; 1973 Mar; 24(3):391-400. PubMed ID: 4713637
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombin activity in the human aortic intima, with special reference to its correlation to atherosclerotic changes].
    Tsubokawa Y
    Jpn Circ J; 1970 Jul; 34(7):631-46. PubMed ID: 4252668
    [No Abstract]   [Full Text] [Related]  

  • 12. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.
    Kurachi K; Fujikawa K; Schmer G; Davie EW
    Biochemistry; 1976 Jan; 15(2):373-7. PubMed ID: 1247523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation of the PPSB fraction in a blood bank].
    Stein P; Vogt M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):334-9. PubMed ID: 4195278
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-Xa activity of human hepatic triglyceride lipase.
    Gray E; Bengtsson-Olivecrona G; Olivecrona T; Barrowcliffe TW
    J Lab Clin Med; 1987 Jun; 109(6):653-9. PubMed ID: 3585139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for designing synthetic, low molecular weight inhibitors of clotting enzymes.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):7-15. PubMed ID: 6177611
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of platelet factor 4 to heparin oligosaccharides.
    Denton J; Lane DA; Thunberg L; Slater AM; Lindahl U
    Biochem J; 1983 Feb; 209(2):455-60. PubMed ID: 6847629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
    Aiach M; Roncato M
    Semin Thromb Hemost; 1985 Apr; 11(2):108-11. PubMed ID: 4035362
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: The relationship between antithrombin III, progressive antithrombin activity and anti Xa activity in plasma.
    Whigham K; Howie PW; Forbes CD; Prentice CR
    Thromb Diath Haemorrh; 1975 Sep; 34(1):365. PubMed ID: 52904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.